Feng Shen - University of Pennsylvania

基本信息

浏览量：1

职业迁徙

个人简介

Feng Shen currently works at the Center for Cellular Immunotherapies, University of Pennsylvania. His most recent work is 'CAR-T and CAR-Macrophage'.

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability

Bakir Valentić,Andre Kelly,Alexander A Shestov, Zhiyang Gan,Feng Shen,Adam Chatoff,Alison Jaccard,Claudia V Crispim,John Scholler,Simon Heeke,Nathaniel W Snyder,Saba Ghassemi, Nicholas Jones,Saar Gill,Roddy S O'Connor

Research square (2024)

引用0浏览0WOS引用

Deletion of CD38 Enhances CD19 Chimeric Antigen Receptor T Cell Function

Kimberly Veliz,Feng Shen,Olga Shestova,Maksim Shestov,Alexander Shestov,Sara Sleiman, Tyler Hansen,Roddy S. O'Connor,Saar Gill

MOLECULAR THERAPY ONCOLOGYno. 2 (2024)

引用1浏览0WOS引用

Ibrutinib Improves Chimeric Antigen Receptor T Cell Control of Leukemia by Inhibiting Myeloid-Derived Suppressor Cells

Benjamin F. Frost,Olga Shestova,Feng Shen,Chia Sharpe,John C. Byrd,Saar I. Gill

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Selective Support of CAR-T Cell Therapies by Cis-Targeted IL2

Sara Sleiman, Tyler Hansen, Hannah Thomas, Jack Swain,Raimon Duran-Struuck,Nathan D. Mathewson,Feng Shen,Kelly D. Moynihan,Paul Bessette,Chris Kimberlin,Meghana Sukthankar,Terrence Park,Andy Yeung,Ivana Djuretic,Saar Gill

MOLECULAR THERAPYno. 4 (2024): 177-177

引用0浏览0引用

Selective Support of CAR-T Cell Therapies by Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates

Sara Sleiman, Tyler Hansen,Nathan D Mathewson,Feng Shen,Miroslaw Kozlowski,Olga Shestova,Maksim Shestov,Danuta Jarocha,Vanessa Gonzalez,Joseph A. Fraietta, Hannah Thomas, Jack Swain,Raimon Duran-Struuck,Kelly D. Moynihan,Paul Bessette,Chris Kimberlin,Meghana Sukthankar,Terrence Park,Andy Yeung,Ivana Djuretic,Saar Gill

Bloodno. Supplement 1 (2024): 499-499

引用0浏览0引用

BTK Inhibition Prevents the Induction of Myeloid-Derived Suppressor Cells in Malignancy and Improves CART Function

Benjamin F. Frost,Olga Shestova,Sara Sleiman, Brandon Simone,Feng Shen,Miroslaw Kozlowski, Michelle Wang,J. Joseph Melenhorst,Noelle Frey,Elizabeth O. Hexner,Megan M. Davis,Joseph A. Fraietta,Avery Gaymon,Rong Xu,Chia Sharpe,John C. Byrd,Mark O'Hara,Adam D. Cohen,Stephen J. Schuster, Donald L. Seigel,Carl H. June,David L. Porter,Saar Gill

Bloodno. Supplement 1 (2024): 909-909

引用0浏览0引用

CD38 As a Pan-Hematologic Target for Chimeric Antigen Receptor T Cells

Tina Glisovic-Aplenc,Caroline Diorio,John A. Chukinas,Kimberly Veliz,Olga Shestova,Feng Shen,Selene Nunez-Cruz,Tiffaney L. Vincent,Fei Miao,Michael C. Milone,Carl H. June,David T. Teachey,Sarah K. Tasian,Richard Aplenc,Saar Gill

BLOOD ADVANCESno. 16 (2023): 4418-4430

引用18浏览0WOS引用

Cis-Targeted Cytokines for Specific Stimulation of CAR T Cells

Sara Sleiman,Nathan D. Mathewson,Feng Shen,Kelly D. Moynihan,Wei Chen,Paul Bessette,Chris Kimberlin,Danielle Pappas,Terrence Park,Andy Yeung,Ivana Djuretic,Saar Gill

MOLECULAR THERAPYno. 4 (2023): 29-30

引用0浏览0引用

Selective Support of CAR-T Cell Therapies by Cis-Targeted IL-2 or IL-21 Cytokines Results in Enhanced Anti-Tumor Activity

Sara Sleiman,Nathan D. Mathewson,Feng Shen,Kelly Moynihan,Wei Chen,Paul Bessette,Chris Kimberlin,Danielle Pappas,Terrence Park,Andy Yeung,Ivana Djuretic,Saar Gill

Blood（2022）

引用0浏览0引用

Rapid Manufacturing of Non-Activated Potent CAR T Cells

Saba Ghassemi,Joseph S. Durgin,Selene Nunez-Cruz,Jai Patel,John Leferovich,Marilia Pinzone,Feng Shen,Katherine D. Cummins,Gabriela Plesa,Vito Adrian Cantu,Shantan Reddy,Frederic D. Bushman,Saar I. Gill,Una O’Doherty,Roddy S. O’Connor,Michael C. Milone

Nature Biomedical Engineering（2022）

引用120浏览0WOSNATURE引用

120

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn